Related references
Note: Only part of the references are listed.Modulating tumor immunity by metronomic dosing of oxaliplatin incorporated in multiple oral nanoemulsion
Jeong Uk Choi et al.
JOURNAL OF CONTROLLED RELEASE (2020)
Bile acid transporter-mediated oral drug delivery
Feiyang Deng et al.
JOURNAL OF CONTROLLED RELEASE (2020)
Enhanced oral bioavailability of an etoposide multiple nanoemulsion incorporating a deoxycholic acid derivative-lipid complex
Saurav Kumar Jha et al.
DRUG DELIVERY (2020)
Metronomic Chemotherapy: A Systematic Review of the Literature and Clinical Experience
Cem Simsek et al.
JOURNAL OF ONCOLOGY (2019)
Five-Year Overall Survival for Patients With Advanced Non-Small-Cell Lung Cancer Treated With Pembrolizumab: Results From the Phase I KEYNOTE-001 Study
Edward B. Garon et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Anti-Angiogenic Effect of Orally Available Pemetrexed for Metronomic Chemotherapy
Ruby Maharjan et al.
PHARMACEUTICS (2019)
Intestinal transport mechanism and in vivo anticancer efficacy of a solid oral formulation incorporating an ion-pairing complex of pemetrexed with deoxycholic acid derivative
Rudra Pangeni et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2019)
Updated Analysis of KEYNOTE-024: Pembrolizumab Versus Platinum-Based Chemotherapy for Advanced Non-Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score of 50% or Greater
Martin Reck et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Immunogenic chemotherapy: Dose and schedule dependence and combination with immunotherapy
Junjie Wu et al.
CANCER LETTERS (2018)
Enhanced oral absorption of pemetrexed by ion-pairing complex formation with deoxycholic acid derivative and multiple nanoemulsion formulations: preparation, characterization, and in vivo oral bioavailability and anticancer effect
Rudra Pangeni et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2018)
Oral pemetrexed facilitates low-dose metronomic therapy and enhances antitumor efficacy in lung cancer
Foyez Mahmud et al.
JOURNAL OF CONTROLLED RELEASE (2018)
Transporter-Guided Delivery of Nanoparticles to Improve Drug Permeation across Cellular Barriers and Drug Exposure to Selective Cell Types
Longfa Kou et al.
FRONTIERS IN PHARMACOLOGY (2018)
Preparation, Characterization, and In Vivo Evaluation of an Oral Multiple Nanoemulsive System for Co-Delivery of Pemetrexed and Quercetin
Rudra Pangeni et al.
PHARMACEUTICS (2018)
Bile Acids and Their Derivatives as Potential Modifiers of Drug Release and Pharmacokinetic Profiles
Nebojsa Pavlovic et al.
FRONTIERS IN PHARMACOLOGY (2018)
Immune checkpoint inhibitors: recent progress and potential biomarkers
Pramod Darvin et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2018)
Lipid drug conjugate nanoparticle as a potential nanocarrier for the oral delivery of pemetrexed diacid: Formulation design, characterization, ex vivo, and in vivo assessment
Kriti Soni et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2017)
Improving intestinal absorption and oral bioavailability of curcumin via taurocholic acid-modified nanostructured lipid carriers
Cihui Tian et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2017)
Elements of cancer immunity and the cancer-immune set point
Daniel S. Chen et al.
NATURE (2017)
Bile acid transporter mediated endocytosis of oral bile acid conjugated nanocomplex
Jooho Park et al.
BIOMATERIALS (2017)
Improvement of paracellular transport in the Caco-2 drug screening model using protein-engineered substrates
Rebecca L. DiMarco et al.
BIOMATERIALS (2017)
Single-Pass Intestinal Perfusion (SPIP) and prediction of fraction absorbed and permeability in humans: A study with antiretroviral drugs
Thaisa Marinho Dezani et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2016)
Metronomic chemotherapy from rationale to clinical studies: A dream or reality?
Antonio Gnoni et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2015)
Absorption-Enhancing Effects of Bile Salts
Eskandar Moghimipour et al.
MOLECULES (2015)
New insights into metronomic chemotherapy-induced immunoregulation
Yi-Bin Hao et al.
CANCER LETTERS (2014)
Metronomics: towards personalized chemotherapy?
Nicolas Andre et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2014)
Bile Acids Modulate Signaling by Functional Perturbation of Plasma Membrane Domains
Yong Zhou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Application of bile acids in drug formulation and delivery
Maja Stojancevic et al.
FRONTIERS IN LIFE SCIENCE (2013)
Treg depletion with a low-dose metronomic temozolomide regimen in a rat glioma model
Claire Banissi et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
Bile acids modulate tight junction structure and barrier function of Caco-2 monolayers via EGFR activation
Francesco Raimondi et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2008)
Pemetrexed pharmacokinetics and pharmacodynamics in a phase I/II study of doublet chemotherapy with vinorelbine: implications for further optimisation of pemetrexed schedules
K. M. Li et al.
BRITISH JOURNAL OF CANCER (2007)
Metronomic cyclophosphamide regimen selectively depletes CD4+ CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patients
Francois Ghiringhelli et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
Novel oral formulation safely improving intestinal absorption of poorly absorbable drugs: Utilization of polyamines and bile acids
M Miyake et al.
JOURNAL OF CONTROLLED RELEASE (2006)
Pemetrexed disodium: A novel Antifolate clinically active against multiple solid tumors
AR Hanauske et al.
ONCOLOGIST (2001)
Share Paper
